These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1568340)

  • 1. Immunospecificity differences between Roche fluorescence polarization immunoassay and Syva EMIT assay of quinidine.
    Malikin G; Lam S
    Clin Chem; 1992 Apr; 38(4):603-5. PubMed ID: 1568340
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluorescence polarization immunoassay of quinidine, procainamide, and N-acetylprocainamide using Cobas-FP reagents.
    Lam YW; Watkins CE
    Clin Pharm; 1993 Jan; 12(1):49-52. PubMed ID: 7679064
    [No Abstract]   [Full Text] [Related]  

  • 3. Quinidine assays: enzyme immunoassay versus high performance liquid chromatography.
    Lehmann CR; Boran KJ; Pierson WP; Melikian AP; Wright GJ
    Ther Drug Monit; 1986; 8(3):336-9. PubMed ID: 3529517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between GC-MS and the EMIT II, Abbott ADx, and Roche OnLine immunoassays for the determination of THCCOOH.
    Kintz P; Machart D; Jamey C; Mangin P
    J Anal Toxicol; 1995 Sep; 19(5):304-6. PubMed ID: 7500617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mercurochrome interference with the Abbott TDx.
    Castellani WJ
    Clin Chem; 1992 Jun; 38(6):1190-1. PubMed ID: 1375874
    [No Abstract]   [Full Text] [Related]  

  • 6. Multicenter evaluation of the Abbott AxSYM procainamide and N-acetylprocainamide assays: comparison with Abbott TDx/TDxFLx, Syva EMIT 2000, DuPont ACA, and HPLC methods.
    Azzazy HM; Chou PP; Poklis A; Shock G; Christenson RH
    Clin Biochem; 1998 Feb; 31(1):55-8. PubMed ID: 9559226
    [No Abstract]   [Full Text] [Related]  

  • 7. Performance of a fluorescence polarization immunoassay system evaluated by therapeutic monitoring of four drugs.
    Zaninotto M; Secchiero S; Paleari CD; Burlina A
    Ther Drug Monit; 1992 Aug; 14(4):301-5. PubMed ID: 1519304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four fluorescence polarization immunoassays for therapeutic drug monitoring evaluated.
    Haver VM; Audino N; Burris S; Nelson M
    Clin Chem; 1989 Jan; 35(1):138-40. PubMed ID: 2463117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Syva Emit 2000 digoxin assay on a Hitachi 717 analyzer.
    Vogl M; Parisch M; Klein C; Müller MM
    Clin Biochem; 1996 Aug; 29(4):389-91. PubMed ID: 8828971
    [No Abstract]   [Full Text] [Related]  

  • 10. Liquid chromatography and fluorescence spectroscopy compared with a homogeneous enzyme immunoassay technique for determining quinidine in serum.
    Drayer DE; Lorenzo B; Reidenberg MM
    Clin Chem; 1981 Feb; 27(2):308-10. PubMed ID: 7006859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three immunoassays for the determination of N-acetylprocainamide. Determination of false elevations by a polyclonal antibody-based method.
    Laurino JP; McKay J; Fischberg E; Schwenzer K; Kaufman R
    Ther Drug Monit; 1994 Jun; 16(3):312-5. PubMed ID: 7521980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid estimation by enzyme immunoassay.
    Elyas AA; Goldberg VD; Ratnaraj N; Lascelles PT
    Ann Clin Biochem; 1980 Nov; 17(6):307-10. PubMed ID: 6782934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The screening for common drugs of abuse in whole blood by means of EMIT-ETS and FPIA-ADx urine immunoassays.
    Maier RD; Erkens M; Hoenen H; Bogusz M
    Int J Legal Med; 1992; 105(2):115-9. PubMed ID: 1520635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External quality assessment of Syva Emit and Abbott TDx II assays for methotrexate in serum.
    Wilson JF; Tsanaclis LM; Barnett K
    Ther Drug Monit; 1996 Dec; 18(6):721-3. PubMed ID: 8946672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme immunoassay and two fluorometric methods compared for the determination of quinidine in serum.
    Pape BE
    Ther Drug Monit; 1981; 3(4):357-63. PubMed ID: 7039008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-‑quality manufactured immunoenzymatic assay kits as a source of confusion in science.
    Chudek J; Bożentowicz-Wikarek M
    Pol Arch Intern Med; 2017 Apr; 127(4):287-288. PubMed ID: 28430169
    [No Abstract]   [Full Text] [Related]  

  • 17. The application of a microcomputer for enzyme immunoassay (Emit) determination of serum quinidine concentrations.
    Sealfon MS; Hallberg N
    Am J Med Technol; 1983 Sep; 49(9):669-70. PubMed ID: 6372484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of oestrogen receptors by enzyme immunoassay.
    Weigand RA; Lynch D; Cotter D
    Eur J Cancer; 1994; 30A(6):888. PubMed ID: 7917554
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance.
    Beck O; Lafolie P; Hjemdahl P; Borg S; Odelius G; Wirbing P
    Clin Chem; 1992 Feb; 38(2):271-5. PubMed ID: 1541010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a commercial enzyme radioimmunoassay kit for serum carcinoembryonic antigen.
    Fabricatorian D; Gallagher ND
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):248-51. PubMed ID: 7025735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.